Ambarella FY2027 Q2业绩符合预期、指引持平，盘后股价下跌

----- d88952d8k.htm -----
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
September 3, 2026
Date of Report (date of earliest event reported)
AMBARELLA, INC.
(Exact name of Registrant as specified in its charter)
Cayman Islands
001-35667
98-0459628
(State or other jurisdiction
of incorporation)
(Commission
File Number)
(I. R. S. Employer
Identification No.)
3001 Tasman Drive
Santa Clara
,
CA
95054
(Address of principal executive offices)
Registrant’s telephone number, including area code:
(408)
734-8888
N/A
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form
8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule
14a-12
under the Exchange Act (17 CFR
240.14a-12)
☐
Pre-commencement
communications pursuant to Rule
14d-2(b)
under the Exchange Act (17 CFR
240.14d-2(b))
☐
Pre-commencement
communications pursuant to Rule
13e-4(c)
under the Exchange Act (17 CFR
240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading
Symbol(s)
Name of each exchange
on which registered
Ordinary Shares, $0.00045 par value
AMBA
The Nasdaq Global Select Market
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule
12b-2
of the Securities Exchange Act of 1934
(§ 240.12b-2
of this chapter).
Emerging growth company
☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02
Results of Operations and Financial Condition
On September 3, 2026, Ambarella, Inc. (the “Company”) issued a press release announcing its financial results for the second quarter of fiscal year 2027 ended July 31, 2026. A copy of the press release is attached as Exhibit 99.1 to this current report on Form
8-K
and is incorporated by reference herein.
The information in Item 2.02 of this current report on Form
8-K
and the exhibits attached hereto shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall they be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any general incorporation language in such filing.
Item 9.01
Financial Statements and Exhibits
(d) Exhibits
99.1
Press Release dated September 3, 2026
104
Cover Page Interactive Data File (embedded within the Inline XBRL document)
Signature
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: September 3, 2026
Ambarella, Inc.
/s/ John A. Young
Chief Financial Officer

----- d88952dex991.htm -----
EX-99.1
2
d88952dex991.htm
EX-99.1
EX-99.1
Exhibit 99.1
Ambarella, Inc. Announces Second Quarter Fiscal Year 2027 Financial Results
September 3, 2026 —Santa Clara, Calif. – Ambarella, Inc. (NASDAQ: AMBA), an edge AI semiconductor company, today announced second quarter
fiscal 2027 financial results for the period ended July 31, 2026.
•
Revenue for the second quarter of fiscal 2027 was $108.1 million, up 13.2% from $95.5 million in the
same period in fiscal 2026. For the six months ended July 31, 2026, revenue was $208.5 million, up 14.9% from $181.4 million for the six months ended July 31, 2025.
•
Gross margin under U.S. generally accepted accounting principles (GAAP) for the second quarter of fiscal 2027 was
57.7%, compared with 58.9% for the same period in fiscal 2026. For the six months ended July 31, 2026, GAAP gross margin was 58.0%, compared with 59.4% for the six months ended July 31, 2025.
•
GAAP net loss for the second quarter of fiscal 2027 was $6.7 million, or loss per diluted ordinary share of
$0.15, compared with a GAAP net loss of $20.0 million, or loss per diluted ordinary share of $0.47, for the same period in fiscal 2026. GAAP net loss for the six months ended July 31, 2026 was $24.8 million or loss per diluted
ordinary share of $0.57. This compares with GAAP net loss of $44.3 million, or loss per diluted ordinary share of $1.05, for the six months ended July 31, 2025.
Financial results on a
non-GAAP
basis for the second quarter of fiscal 2027 are as follows:
•
Gross margin on a
non-GAAP
basis for the second quarter of fiscal 2027
was 59.3%, compared with 60.5% for the same period in fiscal 2026. For the six months ended July 31, 2026,
non-GAAP
gross margin was 59.6%, compared with 61.2% for the six months ended July 31, 2025.
•
Non-GAAP
net income for the second quarter of fiscal 2027 was
$8.2 million, or earnings per diluted ordinary share of $0.18. This compares with
non-GAAP
net income of $6.4 million, or earnings per diluted ordinary share of $0.15, for the same period in fiscal
2026.
Non-GAAP
net income for the six months ended July 31, 2026 was $13.3 million, or earnings per diluted ordinary share of $0.30. This compares with
non-GAAP
net income of $9.5 million, or earnings per diluted ordinary share of $0.22, for the six months ended July 31, 2025.
Based on information available as of today, Ambarella is offering the following guidance for the third quarter of fiscal year 2027, ending October 31,
2026:
•
Revenue is expected to be between $115.0 million and $124.0 million.
•
Gross margin on a
non-GAAP
basis is expected to be between 59.0% and
60.0%.
•
Non-GAAP
operating expenses are expected to be between $56.5 million
and $59.5 million.
Ambarella reports gross margin, net income (loss) and earnings (losses) per share in accordance with GAAP
and, additionally, on a
non-GAAP
basis.
Non-GAAP
financial information excludes the impact of stock-based compensation and acquisition-related costs adjusted for the
associated tax impact, which includes the effect of any benefits or shortfalls recognized. In addition, in our second quarter of fiscal 2027, we recognized a
one-time
$9.0 million reduction in our GAAP
research and development expense on release of a deposit liability following the termination of a development project. Given the nature of this credit and that it is
non-recurring,
we excluded it from
operating expenses for the purpose of reporting
non-GAAP
financial results. A reconciliation of the GAAP to
non-GAAP
gross margin, net income (loss) and earnings
(losses) per share for the periods presented, as well as a description of the items excluded from the
non-GAAP
calculations, is included in the financial statements portion of this press release.
Total cash, cash equivalents and marketable debt securities on hand at the end of the second quarter of fiscal 2027 was $272.3 million, compared with
$277.8 million at the end of the prior quarter and $261.2 million at the end of the same quarter a year ago.
“Our edge AI revenue reached
record levels in Q2, with balanced sequential growth in Auto and IoT markets with very strong growth from our 5nm CV75 and CV72 AI SoCs. We are making significant progress with our strategic priorities to extend our market reach with new higher
value products and the implementation of new
go-to-market
strategies. These include the introduction of our first stand-alone AI Accelerator, X7, and the execution of
7-year
agreements to develop the indirect sales channel with both Macnica, a leading global technical distributor, and CapGemini, a leading global engineering and systems integration firm,” said Fermi Wang,
President & CEO. “These developments are contributing to an increase in our
5-year
serviceable market (“SAM”) forecast for edge AI and Physical AI.”
Quarterly Conference Call
Ambarella plans to hold a
conference call at 4:30 p.m. Eastern Time / 1:30 p.m. Pacific Time today with Fermi Wang, President and Chief Executive Officer, and John Young, Chief Financial Officer, to discuss the second quarter of fiscal year 2027 results. A live and archived
webcast of the call will be available on Ambarella’s website at
http://www.ambarella.com/
for up to 30 days after the call.
About
Ambarella
With an installed base of more than 50 million AI SoC units, Ambarella’s products are utilized in a wide variety of physical edge
AI applications, spanning edge endpoint and edge infrastructure use cases including physical security, vehicle safety, telematics, autonomy, portable video, aerial drones, and other emerging robotic applications. Building on this footprint,
Ambarella offers a full-stack edge AI platform, from highly optimized silicon and programmable software to AI agentic frameworks that coordinate perception, decision-making and control across devices. Ambarella’s
low-power
systems-on-chip
(SoCs) integrate proprietary and highly efficient perception and deep learning neural network AI
accelerators, enabling electronic systems to become more productive with partial or complete levels of machine autonomy. For more information, please visit
www.ambarella.com.
“Safe harbor” statement under the Private Securities Litigation Reform Act of 1995
This press release contains forward-looking statements that are not historical facts and often can be identified by terms such as “outlook,”
“projected,” “intends,” “will,” “estimates,” “anticipates,” “expects,” “believes,” “could,” “should,” or similar expressions, including the
guidance for the third quarter of fiscal year 2027 ending October 31, 2026, and the comments of our CEO relating to demand for edge AI solutions, our progress with strategic priorities to extend our market reach, our ability to successfully
build an indirect sales channel, the forecasted size of our serviceable market (“SAM”), and our ability to successfully penetrate the edge AI and Physical AI markets. The achievement or success of the matters covered by such
forward-looking statements involves risks, uncertainties and assumptions. Our actual results could differ materially from those predicted or implied and reported results should not be considered as an indication of our future performance.
The risks and uncertainties referred to above include, but are not limited to, global economic and political conditions; changes in government policies,
including possible trade tariffs and restrictions; revenue being generated from new customers or design wins, neither of which is assured; the commercial success of our customers’ products; our customers’ ability to manage their
inventory requirements; our growth strategy; our ability to anticipate future market demands and future needs of our customers, particularly for AI inference applications; our ability to introduce, and to generate revenue from, new and enhanced
solutions; our ability to develop, and to generate revenue from, new advanced technologies, such as AI functionality and advanced networks, including vision-language models and GenAI; our ability to retain and expand customer relationships and to
achieve design wins; the expansion of our current markets and our ability to successfully enter new markets and applications, such as edge infrastructure; anticipated trends and challenges, including competition, in the markets in which we operate;
risks associated with global health conditions and associated risk mitigation measures; our ability to effectively manage growth; our ability to retain key employees; and the potential for intellectual property disputes or other litigation.
Further information on these and other factors that could affect our financial results is included in the company’s Annual Report on Form
10-K
for our 2026 fiscal year, which is on file with the Securities and Exchange Commission. Additional information will also be set forth in the company’s quarterly reports on Form
10-Q,
annual reports on Form
10-K
and other filings the company makes with the Securities and Exchange Commission from time to time, copies of which may be obtained by
visiting the Investor Relations portion of our web site at
www.ambarella.com
or the SEC’s web site at www.sec.gov. Undue reliance should not be placed on the forward-looking statements in this release, which are based on information
available to us on the date hereof. The results we report in our Quarterly Report on Form
10-Q
for the second quarter of fiscal 2027 ended July 31, 2026 could differ from the preliminary results announced
in this press release.
Ambarella assumes no obligation and does not intend to update the forward-looking statements made in this press release, except as
required by law.
Non-GAAP
Financial Measures
The company has provided in this release
non-GAAP
financial information, including
non-GAAP
gross margin, net income (loss), and earnings (losses) per share, as a supplement to the condensed consolidated financial statements, which are prepared in accordance with generally accepted
accounting principles (“GAAP”). Management uses these
non-GAAP
financial measures internally in analyzing the company’s financial results to assess operational performance and liquidity. The
company believes that both management and investors benefit from referring to these
non-GAAP
financial measures in assessing its performance and when planning, forecasting and analyzing future periods.
Further, the company believes these
non-GAAP
financial measures are useful to investors because they allow for greater transparency with respect to key financial metrics that the company uses in making
operating decisions and because the company believes that investors and analysts use them to help assess the health of its business and for comparison to other companies.
Non-GAAP
results are presented for
supplemental informational purposes only for understanding the company’s operating results. The
non-GAAP
information should not be considered a substitute for financial information presented in
accordance with GAAP and may be different from
non-GAAP
measures used by other companies.
With respect to its
financial results for the second quarter of fiscal year 2027, the company has provided below reconciliations of its
non-GAAP
financial measures to its most directly comparable GAAP financial measures. With
respect to the company’s expectations for the third quarter of fiscal year 2027, a reconciliation of
non-GAAP
gross margin and
non-GAAP
operating expenses guidance
to the closest corresponding GAAP measure is not available without unreasonable efforts on a forward-looking basis due to the high variability and low visibility with respect to the charges excluded from these
non-GAAP
measures. We expect the variability of the above charges to have a significant, and potentially unpredictable, impact on our future GAAP financial results.
AMBARELLA, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except share and per share data)
(unaudited)
Three Months Ended July 31,
Six Months Ended July 31,
2026
2025
2026
2025
Revenue
$
108,125
$
95,511
$
208,482
$
181,383
Cost of revenue
45,709
39,280
87,477
73,616
Gross profit
62,416
56,231
121,005
107,767
Operating expenses:
Research and development
50,581
59,734
108,721
118,553
Selling, general and administrative
19,978
18,486
39,843
37,061
Total operating expenses
70,559
78,220
148,564
155,614
Loss from operations
(8,143
)
(21,989
)
(27,559
)
(47,847
)
Other income, net
1,806
2,247
3,889
4,422
Loss before income taxes
(6,337
)
(19,742
)
(23,670
)
(43,425
)
Provision for income taxes
352
253
1,112
898
Net loss
$
(6,689
)
$
(19,995
)
$
(24,782
)
$
(44,323
)
Net loss per share attributable to ordinary shareholders:
Basic
$
(0.15
)
$
(0.47
)
$
(0.57
)
$
(1.05
)
Diluted
$
(0.15
)
$
(0.47
)
$
(0.57
)
$
(1.05
)
Weighted-average shares used to compute net loss per share attributable to ordinary
shareholders:
Basic
44,005,576
42,546,979
43,805,429
42,383,475
Diluted
44,005,576
42,546,979
43,805,429
42,383,475
The following tables present details of stock-based compensation, acquisition-related costs and development
project termination credit, included in each functional line item in the condensed consolidated statements of operations above:
Three Months Ended July 31,
Six Months Ended July 31,
2026
2025
2026
2025
(unaudited, in thousands)
Stock-based compensation:
Cost of revenue
$
951
$
780
$
1,734
$
1,731
Research and development
14,007
16,972
27,721
34,557
Selling, general and administrative
7,742
7,436
15,138
15,030
Total stock-based compensation
$
22,700
$
25,188
$
44,593
$
51,318
Three Months Ended July 31,
Six Months Ended July 31,
2026
2025
2026
2025
(unaudited, in thousands)
Acquisition-related costs:
Cost of revenue
$
757
$
757
$
1,514
$
1,514
Research and development
—
—
—
—
Selling, general and administrative
456
456
912
912
Total acquisition-related costs
$
1,213
$
1,213
$
2,426
$
2,426
Three Months Ended July 31,
Six Months Ended July 31,
2026
2025
2026
2025
(unaudited, in thousands)
Development project termination credit:
Cost of revenue
$
—
$
—
$
—
$
—
Research and development
(9,000
)
—
(9,000
)
—
Selling, general and administrative
—
—
—
—
Total development project termination credit
$
(9,000
)
$
—
$
(9,000
)
$
—
The difference between GAAP and
non-GAAP
gross margin was 1.6% and 1.6%, or
$1.7 million and $1.5 million, for the three months ended July 31, 2026 and 2025, respectively. The difference between GAAP and
non-GAAP
gross margin was 1.6% and 1.8%, or $3.2 million and
$3.2 million, for the six months ended July 31, 2026 and 2025, respectively. The differences were due to the effect of stock-based compensation and acquisition-related costs.
AMBARELLA, INC.
RECONCILIATION OF GAAP TO
NON-GAAP
DILUTED EARNINGS (LOSSES) PER SHARE
(in thousands, except share and per share data)
Three Months Ended July 31,
Six Months Ended July 31,
2026
2025
2026
2025
(unaudited)
GAAP net loss
$
(6,689
)
$
(19,995
)
$
(24,782
)
$
(44,323
)
Non-GAAP
adjustments:
Stock-based compensation expense
22,700
25,188
44,593
51,318
Acquisition-related costs
1,213
1,213
2,426
2,426
Development project termination credit
(9,000
)
—
(9,000
)
—
Income tax effect
9
22
29
36
Non-GAAP
net income
$
8,233
$
6,428
$
13,266
$
9,457
GAAP - diluted weighted average shares
44,005,576
42,546,979
43,805,429
42,383,475
Non-GAAP
- diluted weighted average shares
44,515,009
42,946,324
44,207,416
42,698,780
GAAP - diluted net loss per share
$
(0.15
)
$
(0.47
)
$
(0.57
)
$
(1.05
)
Non-GAAP
adjustments:
Stock-based compensation expense
0.52
0.59
1.02
1.21
Acquisition-related costs
0.03
0.03
0.06
0.06
Development project termination credit
(0.20
)
—
(0.21
)
—
Income tax effect
—
—
—
—
Effect of
Non-GAAP
- diluted weighted average
shares
(0.02
)
—
—
—
Non-GAAP
- diluted net income per share
$
0.18
$
0.15
$
0.30
$
0.22
AMBARELLA, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(unaudited, in thousands)
July 31,
2026
January 31,
2026
ASSETS
Current assets:
Cash and cash equivalents
$
101,850
$
191,019
Marketable debt securities
170,482
121,552
Accounts receivable, net
37,440
39,180
Inventories
76,923
52,246
Restricted cash
442
442
Prepaid expenses and other current assets
6,885
5,836
Total current assets
394,022
410,275
Property and equipment, net
12,061
11,553
Intangible assets, net
56,672
58,046
Operating lease
right-of-use
assets, net
10,923
12,118
Goodwill
303,625
303,625
Other
non-current
assets
2,902
2,983
Total assets
$
780,205
$
798,600
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current liabilities:
Accounts payable
26,478
54,029
Accrued and other current liabilities
86,490
97,964
Operating lease liabilities, current
2,229
2,027
Income taxes payable
2,309
1,531
Deferred revenue, current
20,865
22,393
Total current liabilities
138,371
177,944
Operating lease liabilities,
non-current
10,413
11,408
Other long-term liabilities
11,105
14,459
Total liabilities
159,889
203,811
Shareholders’ equity:
Preference shares
—
—
Ordinary shares
20
19
Additional
paid-in
capital
973,864
922,119
Accumulated other comprehensive income (loss)
(864
)
573
Accumulated deficit
(352,704
)
(327,922
)
Total shareholders’ equity
620,316
594,789
Total liabilities and shareholders’ equity
$
780,205
$
798,600
Contact:
Louis Gerhardy
408.636.2310
lgerhardy@ambarella.com